
Industry Viewpoints: Manufacturing IMPs for Clinical Trials
Gowri Sukumar, ESSA Pharmaceuticals, talks to CTA’s Henry Kerali about the challenges of manufacturing IMPs for clinical trials
Gowri Sukumar, ESSA Pharmaceuticals, talks to CTA’s Henry Kerali about the challenges of manufacturing IMPs for clinical trials
Thank you for subscribing to Clinical Trials Arena